Overview of Methotrexate

Client Email Product
Methotrexate
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES
DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

Other Listed Suppliers

0

SERVICES

0

  • FDA
Applications: Direct Compression
Dosage Form: Tablet
More Info on Category: Co-Processed Excipients
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: NF/EP/JP
Technical Specifications: Not Available
  • FDA
Applications: Direct Compression
Dosage Form: Tablet
More Info on Category: Co-Processed Excipients
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: NF/EP/JP
Technical Specifications: Not Available
  • FDA
Applications: Direct Compression
Ingredient(s): Anhydrous Lactose
Dosage Form: Tablet
More Info on Category: Co-Processed Excipients
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: NF/EP/JP
Technical Specifications: Not Available
  • FDA
Applications: Standard Direct Tabletting Or Roller Compaction
Ingredient(s): Anhydrous Lactose
Dosage Form: Tablet
More Info on Category: Co-Processed Excipients
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: NF/EP/JP
Technical Specifications: Not Available
  • FDA
Applications: Direct Tabletting Operations Where Fast Disintegration Is Required
Ingredient(s): Lactose
Dosage Form: Tablet
More Info on Category: Co-Processed Excipients
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: NF/EP/JP
Technical Specifications: Not Available
  • FDA
Applications: Orally Disintegrating Tablets
Ingredient(s): Mannitol
Dosage Form: Tablet
More Info on Category: Co-Processed Excipients
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP/NF
Technical Specifications: Not Available
  • EDQM
Applications: Solubilizer
Ingredient(s): Polysorbate 80
Dosage Form: Tablet, Capsule, Dry Syrup
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Solubilizer in powder form; EXCiPACT
  • FDA
  • EDQM
Applications: It is a Co-Processed Lactose starch for filler/binder having strong disintegrant properties.
Ingredient(s): Lactose
Dosage Form: Tablet, Capsule
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • INJECTABLE;INJECTION - EQ 1GM BASE/40ML (EQ 25MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • INJECTABLE;INJECTION - EQ 50MG BASE/2ML (EQ 25MG BASE/ML)
  • SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 12.5MG/0.4ML (12.5MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 15MG/0.4ML (15MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 17.5MG/0.4ML (17.5MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 20MG/0.4ML (20MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 22.5MG/0.4ML (22.5MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 25MG/0.4ML (25MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 7.5MG/0.4ML (7.5MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 10MG/0.20ML (10MG/0.20ML)
  • SOLUTION;SUBCUTANEOUS - 12.5MG/0.25ML (12.5MG/0.25ML)
  • SOLUTION;SUBCUTANEOUS - 15MG/0.30ML (15MG/0.30ML)
  • SOLUTION;SUBCUTANEOUS - 17.5MG/0.35ML (17.5MG/0.35ML)
  • SOLUTION;SUBCUTANEOUS - 20MG/0.4ML (20MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 22.5MG/0.45ML (22.5MG/0.45ML)
  • SOLUTION;SUBCUTANEOUS - 25MG/0.5ML (25MG/0.5ML)
  • SOLUTION;SUBCUTANEOUS - 27.5MG/0.55ML (27.5MG/0.55ML)
  • SOLUTION;SUBCUTANEOUS - 30MG/0.6ML (30MG/0.6ML)
  • SOLUTION;SUBCUTANEOUS - 7.5MG/0.15ML (7.5MG/0.15ML)
  • SOLUTION;ORAL - EQ 2MG BASE/ML
  • TABLET;ORAL - EQ 2.5MG BASE
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty

Advertise With Us

Advertise With Us